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background:  Coronary artery disease (CAD) is a complex, heritable disease. Genome-wide association studies (GWAS) defined 41 independent 
single-nucleotide polymorphisms (SNPs) associated with an increased risk of CAD, independent of clinical factors. We hypothesized that this genetic 
risk score would also be associated with mortality in a post-myocardial infarction (MI) cohort.
methods: Caucasian patients (N=1956) in the post-MI TRIUMPH cohort were genotyped for the 41 identified SNPs, comprising a genetic risk 
score: a summed product of each risk allele number by its log-transformed OR. Cox proportional hazard models determined the association between 
1-year mortality and the risk-score (as quintiles and as a continuous variable), adjusted for traditional clinical risk factors of: age, sex, BMI, HTN, DM, 
smoking status, statin use, and systolic blood pressure.
results: Mortality was significantly associated with increased risk score quintile (hazard ratio (HR) of Quintile 5 vs. Quintile 1 was 2.229 (95% CI 
= 1.072 - 4.636; P = 0.032; Figure). As a continuous variable, the risk score resulted in a HR of 1.964 per unit increase in score, (95% CI = 1.108-
3.789; P = 0.0442).
Conclusions: This genetic risk score was associated with mortality in a post-MI cohort, independent of traditional clinical risk factors. The 
inclusion of a genetic risk score could allow health care providers to further risk stratify and target the highest risk post-MI patients.
 
